Absolute numbers of regulatory t cells and neutrophils in corticosteroid-free patients are predictive for response to bevacizumab in recurrent glioblastoma patients

HIGHLIGHTS

• who: Véronique Quillien from the Centre Eugène Marquis, rue bataille Flandres Dunkerque, CS44229, Rennes, France have published the research work: Absolute numbers of regulatory T cells and neutrophils in corticosteroid-free patients are predictive for response to bevacizumab in recurrent glioblastoma patients, in the Journal: (JOURNAL)
• what: The aim of the study was to perform a longitudinal follow-up of different circulating immune cells and to highlight those whose rates varied significantly during the course of treatment. The authors were able to show that different populations of circulating cells vary significantly in GBM . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.